These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15529058)
1. New blood thinner offers first potential alternative in 50 years: ximelagatran. Nutescu EA; Helgason CM; Briller J; Schwertz DW J Cardiovasc Nurs; 2004; 19(6):374-83. PubMed ID: 15529058 [TBL] [Abstract][Full Text] [Related]
2. Ximelagatran: a new oral anticoagulant. Hrebickova L; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322 [TBL] [Abstract][Full Text] [Related]
3. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention. Huisman MV; Bounameaux H Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915 [TBL] [Abstract][Full Text] [Related]
4. Prevention of stroke in patients with atrial fibrillation. Olsson SB; Halperin JL Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916 [TBL] [Abstract][Full Text] [Related]
5. Ximelagatran: an orally active direct thrombin inhibitor. Gulseth MP Am J Health Syst Pharm; 2005 Jul; 62(14):1451-67. PubMed ID: 15998925 [TBL] [Abstract][Full Text] [Related]
6. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. Petersen P; Grind M; Adler J; J Am Coll Cardiol; 2003 May; 41(9):1445-51. PubMed ID: 12742279 [TBL] [Abstract][Full Text] [Related]
8. Ximelagatran, the new oral anticoagulant: would warfarin survive the challenge? Mousa SA; Abdel-Razeq HN Cardiovasc Drug Rev; 2005; 23(4):331-44. PubMed ID: 16614732 [TBL] [Abstract][Full Text] [Related]
9. Ximelagatran: direct thrombin inhibitor. Ho SJ; Brighton TA Vasc Health Risk Manag; 2006; 2(1):49-58. PubMed ID: 17319469 [TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
12. Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation? Reiffel JA Curr Opin Cardiol; 2004 Jan; 19(1):58-63. PubMed ID: 14688636 [TBL] [Abstract][Full Text] [Related]
13. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation. Halperin JL J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364 [TBL] [Abstract][Full Text] [Related]
14. Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolism. Haas S Drugs; 2004; 64 Suppl 1():7-16. PubMed ID: 15586623 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor. Halperin JL Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465 [TBL] [Abstract][Full Text] [Related]
16. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C; Mouret P Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914 [TBL] [Abstract][Full Text] [Related]
17. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era.. Mohapatra R; Tran M; Gore JM; Spencer FA Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146 [TBL] [Abstract][Full Text] [Related]
18. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210 [TBL] [Abstract][Full Text] [Related]
19. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. Albers GW; Diener HC; Frison L; Grind M; Nevinson M; Partridge S; Halperin JL; Horrow J; Olsson SB; Petersen P; Vahanian A; JAMA; 2005 Feb; 293(6):690-8. PubMed ID: 15701910 [TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Albers GW; Am J Manag Care; 2004 Dec; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]